Best Medical Cannabis Clinics UK — Top 5 Reviewed & Compared

Releaf has achieved the most remarkable growth trajectory of any UK medical cannabis clinic — launching in February 2024 and within 18 months establishing itself as the highest-rated clinic in the UK by Trustpilot score and volume. With over 7,000 verified reviews at 4.8 stars as of mid-2026, Releaf has achieved what many clinic comparison sites describe as the most reliable independent signal of quality in the market — both the highest rating and the largest review base simultaneously.

Releaf's market positioning is explicitly premium. The £99.99 initial consultation is the most expensive first-appointment fee of any clinic reviewed here, and the £39.99 per month Releaf+ subscription is nearly eight times the cost of Alternaleaf's £5/month plan. What patients get for that premium is substantial: a comprehensively staffed clinical team of 30+ specialists, an integrated patient portal and app, same-day prescription management, unlimited follow-up appointments, a physical Medical Cannabis Card, and — uniquely in the UK — access to UK-grown medical cannabis flower through a strategic partnership with Glass Pharms in Wiltshire.

The Glass Pharms partnership deserves particular attention. UK-grown medical cannabis addresses a significant concern for many patients — the supply chain reliability and freshness concerns associated with imported pharmaceutical cannabis. Releaf patient Chloe Durrington became the first person in UK history to receive a prescription for domestically grown medical cannabis flower, a milestone announced in The Sunday Times. For patients who prioritise UK provenance and minimise concerns about import logistics, this is a genuine differentiator.

Conditions Treated

Pricing Detail

Initial consultation: £99.99 — 30-minute video consultation with a GMC-registered specialist. Full money-back guarantee if deemed ineligible. Releaf states 9 out of 10 patients are successfully prescribed.

Releaf+ subscription: £39.99 per month — includes all follow-up appointments (unlimited 15-minute sessions or secure messaging), prescription management, physical Medical Cannabis Card, patient portal access, and priority stock alerts. At £7.99 per gram for flower (Releaf+ price), the medication cost sits slightly below mid-market.

Medication: Flower from £7.99/gram for Releaf+ patients. Oils, capsules, and sprays available at varying prices. UK-grown Glass Pharms flower available as a premium option.

Patient Reviews

Releaf's Trustpilot profile is the most consistently positive of any UK medical cannabis clinic — reviewers across thousands of verified reviews repeatedly highlight three specific qualities: the professionalism and warmth of individual specialist doctors, the speed of the process from consultation to delivery, and the app/portal experience. The review sentiment is notably more positive on the clinical experience than the billing experience — some patients express frustration at the subscription model when circumstances change.

Alternaleaf has built its market position on a single compelling proposition: the most accessible medical cannabis in the UK at the lowest price in the market. With an initial consultation from £29 and a subscription of just £5 per month covering all required appointments, Alternaleaf has made medical cannabis accessible to UK patients who would be priced out of clinics like Releaf or Mamedica. The result is the second largest patient base of any UK clinic — over 50,000 patients — and the second highest Trustpilot review volume at 5,300+ reviews.

Alternaleaf operates as a fully online clinic — all appointments via video call, prescriptions issued digitally, medication delivered to the patient's home through pharmacy partners. The clinical team is GMC-registered and trained in medical cannabis prescribing. The patient journey is deliberately streamlined: free eligibility checker, £29 initial appointment, follow-up at 3-4 weeks, then reviews every 6 months. The £5/month subscription covers every required appointment in that cycle — a remarkably low annual cost of £60 for all clinical oversight excluding medication.

The trade-off for the low price is the absence of the premium features that distinguish Releaf — no integrated patient app of comparable depth, no physical cannabis card as standard, and a more limited medication formulary than the largest clinics. Patients with complex or multi-system conditions may find the more generalist clinical team less suited to their needs than the specialist-heavy teams at Releaf or Mamedica.

Conditions Treated

Pricing Detail

Initial consultation: £29 — covers initial assessment and first doctor appointment. No charge if ineligible. The most affordable first-appointment cost of any major UK clinic.

Subscription: £5/month — covers all required appointments for the treatment cycle. Annual equivalent: £60. The cheapest ongoing clinic fee in the UK market.

Pay-as-you-go: £29 per appointment — for patients who prefer not to commit to a monthly fee. Each consultation billed individually.

Medication: Priced through pharmacy partners — varies by prescription. Not included in subscription.

Patient Reviews

Alternaleaf's Trustpilot profile is strongly positive — the most common praise focuses on the accessibility and affordability of the service, the compassionate approach of individual doctors, and the smoothness of the prescription and delivery process. The MedicalCannabis.co.uk score of 2.7 (significantly lower than the Trustpilot 4.6) is notable and likely reflects a different patient demographic leaving reviews — longer-term patients with more complex expectations may represent a higher proportion of the specialist platform's reviewers.

Mamedica occupies an interesting position in the UK medical cannabis clinic market — higher initial consultation fees than mid-market competitors, but a unique long-term pricing model that eliminates clinic fees entirely from year two onwards. Founded in 2022 by Jon Robson and CQC-registered, Mamedica has grown rapidly to serve 15,000+ patients and was ranked number 8 in The Sunday Times 100 2026 as one of the UK's fastest-growing private companies — a remarkable distinction that reflects both its growth trajectory and business model credibility.

The Mamedica pricing structure deserves careful attention. The £150 initial consultation is the highest first-appointment fee of any clinic reviewed, which creates a significant barrier to entry. However, from year two onwards, Mamedica charges zero clinic fees — the lowest long-term ongoing cost of any clinic. For patients who remain with Mamedica beyond the first year, the total cost of clinical oversight becomes the lowest in the market. This makes Mamedica particularly attractive to patients with long-term chronic conditions who anticipate needing ongoing treatment for years rather than months.

Mamedica has also developed its own branded cannabis products — available exclusively through the clinic — giving patients access to formulations specifically selected and QA-tested by the Mamedica clinical team. The clinic treats a focused range of conditions: chronic pain, PTSD, epilepsy, cancer-related symptoms, and Tourette syndrome are its stated specialisations, suggesting a more selective clinical approach than the broad condition lists of Alternaleaf or Curaleaf.

Conditions Treated

Pricing Detail

Initial consultation: £150 — the most expensive initial appointment of any clinic reviewed. Same-week video slots typically available including evenings and Saturdays.

Year 1 follow-up: £75 per ad-hoc review if needed, with first annual review included. Year 1 total clinic fees: approximately £150-£225.

From year 2: Zero clinic fees — all follow-up appointments free. The lowest ongoing cost in the market for established patients. This is Mamedica's core USP and the primary reason for its differentiated market positioning.

Medication: Priced through pharmacy partners plus Mamedica's own branded product range. Delivery free.

Patient Reviews

Mamedica's Trustpilot reviews consistently praise three specific aspects: the professionalism and helpfulness of staff, the simplicity and clarity of the onboarding process, and the quality of the products prescribed. The clinic's CQC registration and transparent pricing structure are frequently mentioned as trust-building factors. The occasional negative review centres on the high initial consultation cost and occasional scheduling delays.

Curaleaf Clinic — formerly Sapphire Medical — is the longest-established major UK medical cannabis clinic, operating since 2016 as Sapphire before rebranding under the Curaleaf name in 2022. This seven-year-plus track record gives Curaleaf a clinical experience depth that newer clinics cannot match — the team has been prescribing cannabis-based medicines in the UK since before the formal legalisation framework existed, having been involved in NHS approved clinical trials. Curaleaf won Cannabis Clinic of the Year 2024, a recognition of its clinical standards and patient experience.

Curaleaf's pricing has evolved to become one of the most competitive in the market — the £5/month subscription (or £50/year) includes all routine appointments and follow-ups, with £30 pay-per-appointment as the alternative. This positions Curaleaf directly against Alternaleaf on price while offering the additional credibility of the longest operating history in UK medical cannabis. The clinic offers both online consultations and access to physical clinic locations — a differentiator for patients who prefer face-to-face assessment or who find video consultations challenging.

The mixed review picture for Curaleaf is worth understanding contextually. The 4.6★ Trustpilot rating from 2,570+ reviews is strong, but the MedicalCannabis.co.uk score of 2.9 is notably lower. This divergence appears to reflect product availability and formulary issues that have affected some patients — Curaleaf's stock management has drawn criticism from some long-term patients when preferred strains become unavailable. This is an industry-wide issue but has been more prominently noted in Curaleaf feedback than at Releaf or Mamedica.

Conditions Treated

Pricing Detail

Annual subscription: £50/year or £5/month — covers all initial and routine appointments, prescription renewals, and ongoing support. Free home delivery on medication. No admin fees for repeat prescriptions.

Pay-as-you-go: £30 per appointment — for patients who prefer appointment-by-appointment billing.

Medication: Via Curaleaf's integrated pharmacy network. Free home delivery standard. Product range includes flower, oils, capsules, and sprays.

Patient Reviews

Curaleaf's Trustpilot reviewers consistently praise the quality and knowledge of individual specialists — particularly regarding strain knowledge and terpene understanding — and the speed of customer service issue resolution. The negative feedback centres on stock availability and the impact on treatment continuity when preferred medications are unavailable. The physical clinic option is specifically mentioned positively by patients who value face-to-face consultation.

Lyphe — formerly The Medical Cannabis Clinics (TMCC) — is one of the UK's longest-operating medical cannabis providers, established in 2019 and recently acquired by US cannabis giant Tilray. Rebranded as Lyphe in 2024 under new ownership and management since January 8th 2024, the clinic claims to be the largest in the UK by patient numbers and specialises in neurology, pain, and psychiatry — the three clinical domains most commonly associated with medical cannabis prescribing. The Tilray acquisition brings significant capital backing and the potential for deeper pharmaceutical relationships, though it has also created a period of transition that has been noted in patient reviews.

Lyphe's pricing sits in the middle of the market — an initial consultation of £149 (similar to Mamedica's £150), with ongoing subscription options from £9.99/month or £99.99/year. The subscription covers all follow-up appointments every 90 days. The clinic operates an integrated model — Lyphe Dispensary is the default pharmacy partner, creating a more controlled medication supply chain than clinics that use multiple independent pharmacy partners. Live chat and email support are available until 8pm on weekdays — later than most competitors.

The Trustpilot profile at 4.0 stars is the lowest of the five clinics reviewed — but the context is important. Many of the lower reviews relate to the transition period following the January 2024 rebranding and ownership change from TMCC to Lyphe. More recent reviews (2025-2026) show notably higher satisfaction scores as the new management team has stabilised operations. The claim to be "the largest clinic specialising in medical cannabis in the UK" is frequently repeated but not independently verified — patient registration numbers are not publicly available for any UK clinic.

Conditions Treated

Pricing Detail

Initial consultation: £149 — comprehensive specialist assessment. The second most expensive initial consultation after Mamedica.

Monthly subscription: £9.99/month — covers all follow-up appointments every 90 days. Annual equivalent £119.88, or £99.99 if paid annually upfront.

Pay-as-you-go: £49 per follow-up appointment — for patients outside the subscription model.

Repeat prescriptions: £30 for PAYG patients — free for subscription members.

Medication: Via Lyphe Dispensary (integrated pharmacy). Free clinic transfer for existing CBPM patients moving from other clinics.

Patient Reviews

Lyphe's Trustpilot reviews split noticeably between pre and post-2024 rebrand experiences. More recent 2025-2026 reviews show improved satisfaction under the new management — patients frequently praising the staff warmth, clinical knowledge, and medication quality. Older reviews from the TMCC-to-Lyphe transition period drag the overall average down significantly. The extended support hours (8pm weekdays) and the free clinic transfer policy are specifically called out positively by reviewers who switched from other clinics.